Files
Download Full Text (365 KB)
Contents
- Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
- Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
- Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
- HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy
Publication Date
4-1-2017
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Hanasono, Matthew M.; Chang, Edward; Schaverien, Mark V.; Wang, Michael; Romaguera, Jorge; Dmitrovsky, Ethan; Abudayyeh, Ala; Fadol, Anecita P.; Hutcheson, Katherine; Lymphedema -- surgery; Edema; Patients; Lymphoma, Mantle-Cell; Immunotherapy; Antineoplastic Agents; Clinical Trials as Topic; Lymphoma, B-Cell; Cancer Survivors; BK Virus; Ventricular Dysfunction, Left; Antibodies, Monoclonal; Immune Checkpoint Inhibitors; Cytokines; Breathing Exercises; Lymph Nodes -- surgery.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Tutt, Bryan and Bronson, Sarah, "OncoLog, Volume 62, Number 04, April 2017" (2017). OncoLog MD Anderson's Report to Physicians (All issues). 279.
https://openworks.mdanderson.org/oncolog/279
Conditions Governing Access
Redacted
